{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T21:49:09Z","timestamp":1740174549933,"version":"3.37.3"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,16]],"date-time":"2016-10-16T00:00:00Z","timestamp":1476576000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Grants-in-Aid","award":["15K15733"],"award-info":[{"award-number":["15K15733"]}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology of Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regenerative Therapy"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.reth.2016.11.002","type":"journal-article","created":{"date-parts":[[2017,1,26]],"date-time":"2017-01-26T02:01:27Z","timestamp":1485396087000},"page":"15-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Impairment of the transition from proliferative stage to prehypertrophic stage in chondrogenic differentiation of human induced pluripotent stem cells harboring the causative mutation of\u00a0achondroplasia in fibroblast growth factor receptor 3"],"prefix":"10.1016","volume":"6","author":[{"given":"Naohiro","family":"Horie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuhiko","family":"Hikita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Nishizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakura","family":"Uto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Takato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuto","family":"Hoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.reth.2016.11.002_bib1","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0140-6736(07)61090-3","article-title":"Achondroplasia","volume":"370","author":"Horton","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.reth.2016.11.002_bib2","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1017\/erm.2012.4","article-title":"FGFR3 targeting strategies for achondroplasia","volume":"14","author":"Laederich","year":"2012","journal-title":"Expert Rev Mol Med"},{"key":"10.1016\/j.reth.2016.11.002_bib3","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1128\/MCB.20.2.516-522.2000","article-title":"The transmembrane mutation G380R in fibroblast growth factor receptor 3 uncouples ligand-mediated receptor activation from down-regulation","volume":"20","author":"Monsonego-Ornan","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.reth.2016.11.002_bib4","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1073\/pnas.2237184100","article-title":"Defective lysosomal targeting of activated fibroblast growth factor receptor 3 in achondroplasia","volume":"101","author":"Cho","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.reth.2016.11.002_bib5","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.1073\/pnas.96.8.4455","article-title":"A\u00a0mouse model for achondroplasia produced by targeting fibroblast growth factor receptor 3","volume":"96","author":"Wang","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.reth.2016.11.002_bib6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000446958","article-title":"Height outcome of recombinant human growth hormone treatment in achondroplasia children: a meta-analysis","volume":"86","author":"Miccoli","year":"2016","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.reth.2016.11.002_bib7","doi-asserted-by":"crossref","first-page":"R2","DOI":"10.1093\/hmg\/ddv419","article-title":"Advances in treatment of achondroplasia and osteoarthritis","volume":"25","author":"Klag","year":"2016","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.reth.2016.11.002_bib8","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nature13775","article-title":"Statin treatment rescues FGFR3 skeletal dysplasia phenotypes","volume":"513","author":"Yamashita","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.reth.2016.11.002_bib9","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.reth.2016.11.002_bib10","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.stem.2013.01.009","article-title":"Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular A\u03b2 and differential drug responsiveness","volume":"12","author":"Kondo","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.reth.2016.11.002_bib11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/humu.21636","article-title":"Sixteen years and counting: the current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasias","volume":"33","author":"Foldynova-Trantirkova","year":"2012","journal-title":"Hum Mutat"},{"key":"10.1016\/j.reth.2016.11.002_bib12","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/(SICI)1098-1004(1999)14:2<115::AID-HUMU3>3.0.CO;2-2","article-title":"Clinical spectrum of fibroblast growth factor receptor mutations","volume":"14","author":"Passos-Bueno","year":"1999","journal-title":"Hum Mutat"},{"key":"10.1016\/j.reth.2016.11.002_bib13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nbt1374","article-title":"Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts","volume":"26","author":"Nakagawa","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.reth.2016.11.002_bib14","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/nbt.1683","article-title":"Directed differentiation of human embryonic stem cells toward chondrocytes","volume":"28","author":"Oldershaw","year":"2010","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.reth.2016.11.002_bib15","doi-asserted-by":"crossref","DOI":"10.1126\/science.1258096","article-title":"Genome editing. The new frontier of genome engineering with CRISPR-Cas9","author":"Doudna","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.reth.2016.11.002_bib16","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.tibtech.2013.04.004","article-title":"ZFN, TALEN, and CRISPR\/Cas-based methods for genome engineering","volume":"31","author":"Gaj","year":"2013","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.reth.2016.11.002_bib17","doi-asserted-by":"crossref","DOI":"10.1111\/gtc.12437","article-title":"Highly multiplexed CRISPR-Cas9-nuclease and Cas9-nickase vectors for inactivation of hepatitis B virus","author":"Sakuma","year":"2016","journal-title":"Genes Cells"},{"key":"10.1016\/j.reth.2016.11.002_bib18","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.stem.2014.06.011","article-title":"Whole-genome sequencing analysis reveals high specificity of CRISPR\/Cas9 and TALEN-based genome editing in human iPSCs","volume":"15","author":"Smith","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.reth.2016.11.002_bib19","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1242\/dev.105536","article-title":"A\u00a0pathway to bone: signaling molecules and transcription factors involved in chondrocyte development and maturation","volume":"142","author":"Kozhemyakina","year":"2015","journal-title":"Development"},{"key":"10.1016\/j.reth.2016.11.002_bib20","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.devcel.2007.09.016","article-title":"Snail1 is a transcriptional effector of FGFR3 signaling during chondrogenesis and achondroplasias","volume":"13","author":"de Frutos","year":"2007","journal-title":"Dev Cell"}],"container-title":["Regenerative Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352320416300608?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352320416300608?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T14:40:34Z","timestamp":1565361634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352320416300608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":20,"alternative-id":["S2352320416300608"],"URL":"https:\/\/doi.org\/10.1016\/j.reth.2016.11.002","relation":{},"ISSN":["2352-3204"],"issn-type":[{"type":"print","value":"2352-3204"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impairment of the transition from proliferative stage to prehypertrophic stage in chondrogenic differentiation of human induced pluripotent stem cells harboring the causative mutation of\u00a0achondroplasia in fibroblast growth factor receptor 3","name":"articletitle","label":"Article Title"},{"value":"Regenerative Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reth.2016.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017, The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}